BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 7591754)

  • 1. Physician attitudes toward pharmaceutical sales representatives.
    Andaleeb SS; Tallman RF
    Health Care Manage Rev; 1995; 20(3):68-76. PubMed ID: 7591754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships of physicians with pharmaceutical sales representatives and pharmaceutical companies: an exploratory study.
    Anadaleeb SS; Tallman RF
    Health Mark Q; 1996; 13(4):79-89. PubMed ID: 10159647
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of services provided by pharmaceutical companies: perceptions of physicians and pharmaceutical sales representatives.
    Gaedeke RM; Tootelian DH; Sanders EE
    Health Mark Q; 1999; 17(1):23-31. PubMed ID: 11066720
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Factors associated with physicians' reliance on pharmaceutical sales representatives.
    Anderson BL; Silverman GK; Loewenstein GF; Zinberg S; Schulkin J
    Acad Med; 2009 Aug; 84(8):994-1002. PubMed ID: 19638762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Family doctors' views of pharmaceutical sales representatives: assessment scale development.
    Kersnik J; Klemenc-Ketis Z; Petek-Ster M; Tusek-Bunc K; Poplas-Susic T; Kolsek M
    Fam Pract; 2011 Aug; 28(4):456-60. PubMed ID: 21292626
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacists' and physicians' attitudes toward pharmaceutical marketing practices.
    Poirier TI; Giannetti V; Giudici RA
    Am J Hosp Pharm; 1994 Feb; 51(3):378-81. PubMed ID: 8160692
    [No Abstract]   [Full Text] [Related]  

  • 7. Physicians' perceptions and uses of commercial drug information sources: an examination of pharmaceutical marketing to physicians.
    Spiller LD; Wymer WW
    Health Mark Q; 2001; 19(1):91-106. PubMed ID: 11727295
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmaceutical drug marketing strategies and tactics: a comparative analysis of attitudes held by pharmaceutical representatives and physicians.
    Parker RS; Pettijohn CE
    Health Mark Q; 2005; 22(4):27-43. PubMed ID: 16597582
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Attitudes of general practitioners to pharmaceutical sales representatives in Sousse].
    Ben Abdelaziz A; Harrabi I; Rahmani S; Ghedira A; Gaha K; Ghannem H
    East Mediterr Health J; 2003; 9(5-6):1075-83. PubMed ID: 16450540
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Interactions with the pharmaceutical industry: experiences and attitudes of psychiatry residents, interns and clerks.
    Hodges B
    CMAJ; 1995 Sep; 153(5):553-9. PubMed ID: 7641153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characteristics of physicians who frequently see pharmaceutical sales representatives.
    Alkhateeb FM; Khanfar NM; Clauson KA
    J Hosp Mark Public Relations; 2009; 19(1):2-14. PubMed ID: 19197653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Marketing pharmaceutical products to physicians. Sales reps influence physicians' impressions of the industry.
    Creyer EH; Hrsistodoulakis I
    Mark Health Serv; 1998; 18(2):34-8. PubMed ID: 10180333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study of interactions between pharmaceutical representatives and ophthalmology trainees.
    Wang Y; Adelman RA
    Am J Ophthalmol; 2009 Oct; 148(4):619-622.e3. PubMed ID: 19570520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attitudes and beliefs regarding direct-to-consumer advertising of pharmaceutical drugs: an exploratory comparison of physicians and pharmaceutical sales representatives.
    Schulz SA; Broekemier GM; Burkink TJ
    Health Mark Q; 2014; 31(3):279-91. PubMed ID: 25120047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interactions between physicians and the pharmaceutical industry generally and sales representatives specifically and their association with physicians' attitudes and prescribing habits: a systematic review.
    Fickweiler F; Fickweiler W; Urbach E
    BMJ Open; 2017 Sep; 7(9):e016408. PubMed ID: 28963287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Attitudes of physicians toward formularies and services provided by pharmacists.
    Sansgiry SS; Hayes JD; Rice GK
    Manag Care Interface; 2003 Feb; 16(2):34-8. PubMed ID: 12647524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structured approach to pharmaceutical representatives. Family medicine residency program.
    Kelcher S; Brownoff R; Meadows LM
    Can Fam Physician; 1998 May; 44():1053-6, 1059-60. PubMed ID: 9612591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes.
    Wofford JL; Ohl CA
    BMC Med Educ; 2005 Feb; 5(1):5. PubMed ID: 15698480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. What information do physicians receive from pharmaceutical representatives?
    Lexchin J
    Can Fam Physician; 1997 May; 43():941-5. PubMed ID: 9154366
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethics, profit and patients: when pharmaceutical companies sponsor medical meetings.
    Barton L
    J Hosp Mark; 1993; 8(1):71-82. PubMed ID: 10135504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.